MRZMMarizyme, Inc.

$0.00
$0.00
(0.00%)
Today
Updated: 01:33 PM EDT
Mkt Cap$132.00
Vol92.00

About

Marizyme, Inc. is a medical technology company, which engages in the acquisition, development, and commercialization of therapies that minimize mortality and costs in the acute care space. It offers DuraGraft, a one-time intraoperative vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure, and Krillase, a patented protease-based therapeutic. The company was founded on March 20, 2007 and is headquartered in Jupiter, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Marizyme Inc?
What is the 52-week high for Marizyme Inc?

Latest MRZM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.